14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.01 $5.59 Thursday, 2nd May 2024 NEXI stock ended at $3.12. This is 1.89% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 3.48% from a day low at $3.07 to a day high of $3.18.
90 days $3.01 $19.65
52 weeks $0.150 $28.69

Historical NexImmune, Inc. prices

Date Open High Low Close Volume
Jan 16, 2024 $10.41 $11.44 $9.62 $10.15 203 571
Jan 12, 2024 $11.89 $13.46 $9.31 $9.96 627 286
Jan 11, 2024 $12.30 $13.38 $11.25 $11.69 919 182
Jan 10, 2024 $11.20 $14.61 $10.55 $11.90 3 424 766
Jan 09, 2024 $8.12 $16.56 $8.12 $11.80 16 866 943
Jan 08, 2024 $6.34 $9.44 $6.31 $7.57 6 227 302
Jan 05, 2024 $5.75 $8.34 $5.75 $6.18 6 961 524
Jan 04, 2024 $6.11 $6.20 $5.31 $5.90 1 211 111
Jan 03, 2024 $7.35 $10.97 $5.87 $6.20 61 180 571
Jan 02, 2024 $2.32 $2.60 $2.32 $2.38 19 973
Dec 29, 2023 $2.22 $2.22 $2.08 $2.22 20 565
Dec 28, 2023 $2.10 $2.21 $2.07 $2.17 19 391
Dec 27, 2023 $2.26 $2.26 $2.11 $2.12 8 376
Dec 26, 2023 $2.34 $2.57 $2.18 $2.18 33 949
Dec 22, 2023 $2.33 $2.59 $2.26 $2.33 39 532
Dec 21, 2023 $2.29 $2.36 $2.25 $2.25 14 310
Dec 20, 2023 $2.59 $2.68 $2.24 $2.26 76 779
Dec 19, 2023 $2.36 $2.68 $2.36 $2.60 59 875
Dec 18, 2023 $2.48 $2.49 $2.35 $2.44 19 731
Dec 15, 2023 $3.11 $3.28 $2.31 $2.46 94 517
Dec 14, 2023 $3.13 $3.31 $3.10 $3.16 9 896
Dec 13, 2023 $3.10 $3.21 $3.10 $3.19 27 798
Dec 12, 2023 $3.38 $3.52 $3.10 $3.32 37 793
Dec 11, 2023 $3.51 $3.74 $3.34 $3.48 79 968
Dec 08, 2023 $3.58 $3.83 $3.44 $3.68 53 070
Click to get the best stock tips daily for free!

About NexImmune, Inc.

NexImmune. NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials f... NEXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT